CAM
CRL icon

Capstone Asset Management’s Charles River Laboratories CRL Stock Holding History

Capstone Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$2.37M Buy
23,378
+18,706
+400% +$1.72M 0.07% 352
2017
Q1 		$420K Sell
4,672
-4,060
-46% -$345K 0.01% 1029
2016
Q4 		$665K Sell
8,732
-860
-9% -$65.3K 0.02% 758
2016
Q3 		$799K Sell
9,592
-250
-3% -$21K 0.02% 679
2016
Q2 		$811K Buy
9,842
+1,420
+17% +$117K 0.02% 664
2016
Q1 		$640K Buy
8,422
+470
+6% +$34.8K 0.02% 769
2015
Q4 		$639K Buy
7,952
+710
+10% +$51.2K 0.02% 769
2015
Q3 		$460K Buy
7,242
+950
+15% +$68.2K 0.01% 972
2015
Q2 		$443K Buy
6,292
+260
+4% +$19.2K 0.01% 1043
2015
Q1 		$478K Sell
6,032
-130
-2% -$9.59K 0.01% 1109
2014
Q4 		$392K Sell
6,162
-260
-4% -$16.3K 0.01% 1207
2014
Q3 		$384K Buy
6,422
+100
+2% +$5.72K 0.01% 1187
2014
Q2 		$338K Sell
6,322
-340
-5% -$18.7K 0.01% 1319
2014
Q1 		$402K Sell
6,662
-100
-1% -$5.83K 0.01% 1228
2013
Q4 		$359K Sell
6,762
-4,238
-39% -$213K 0.01% 1382
2013
Q3 		$509K Buy
11,000
+380
+4% +$17.4K 0.01% 1283
2013
Q2 		$436K Buy
+10,620
New +$455K 0.01% 1304

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capstone Asset Management's CRL Position: Q2 2017 in Review

Capstone Asset Management increased its Charles River Laboratories (CRL) stake by 400% in Q2 2017, buying an estimated $1.72M and bringing the position to 23,378 shares worth $2.37M. The position accounts for 0.07% of the portfolio, ranked #352.

Capstone Asset Management first reported a position in CRL in Q2 2013 and has held it in 17 quarters since. 302 funds tracked by Wall St. Rank hold CRL as of Q2 2017.

  • Capstone Asset Management held 23,378 shares of Charles River Laboratories worth $2.37M as of Q2 2017.
  • Capstone Asset Management bought 18,706 Charles River Laboratories shares in Q2 2017, an estimated $1.72M.
  • Charles River Laboratories made up 0.07% of Capstone Asset Management's portfolio in Q2 2017, its #352 holding.
  • Capstone Asset Management first reported a position in Charles River Laboratories in Q2 2013 and has held it in 17 quarters since.
  • 302 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.